Germany Oncology Drugs Market Analysis

Germany Oncology Drugs Market Analysis


$ 3999

The oncology drugs market in Germany is a significant and growing market, as cancer is a major public health issue. According to a report published by Insights10, the oncology drugs market in Germany was valued at $7.19 Bn in 2022 and is expected to reach $15.19 Bn by 2030, at a CAGR of 9.8% during the forecast period. The market is highly competitive, with a large number of players like Baxter, Daiichi Sankyo Europe, Novartis etc offering a wide range of cancer treatment options.

ID: IN10DEPH018 CATEGORY: Pharmaceuticals GEOGRAPHY: Germany

Buy Now

Germany Oncology Drugs Market Executive Summary

The Germany oncology drugs market size is at around $7.19 Bn in 2022 and is projected to reach $15.19 Bn in 2030, exhibiting a CAGR of 9.8% during the forecast period. Germany spends an average of 11.1% of its GDP on healthcare and is one of the European nations with the highest healthcare expenditures. Health spending in Germany hit a record high of $462.96 Bn in the COVID-19 pandemic year of 2020. In Germany, healthcare costs accounted for 13.1% of GDP in 2020 and rose by 1.2% in 2021. Most of the diseases that are prevalent in Germany are comparable to those that are prevalent in other affluent nations. The World Health Organization (WHO) reports that cancer and cardiovascular diseases, including heart attacks and strokes, are the two major causes of fatalities in Germany.

Germany has an age-standardized incidence rate of cancer of roughly 430 cases per 100,000 people. A cancer diagnosis is made in roughly 4.3% of the population each year. The number of incident cases of cancer in 2020 was reported to be 538,140 by the World Cancer Research Fund International.

The oncology drugs market in Germany consists of a wide range of products and services related to the treatment and management of cancer. This includes drugs and medical devices used in cancer diagnosis and treatment, such as imaging equipment and radiation therapy machines. Services include pain management medications and home health care services for cancer patients. The government also plays an active role in the regulation of therapeutics in the oncology segment and excessive pressure on price regulation policies is a challenge among pharmaceutical manufacturers and the country frequently faces a shortage of medicines.

Germany Oncology Drugs Market Analysis

Market Dynamics

Market Growth Drivers

There are several factors that may be driving the market for oncology treatments in Germany. These may include:

  • Increasing incidence of cancer: The incidence of cancer is increasing globally, and Germany is no exception. The age-standardized incidence rate of cancer in Germany is about 430 cases per 100,000 population.
  • Increasing funding for cancer research: Governments and private organizations are increasing their funding for cancer research, which is expected to drive the development of new treatments and therapies. This, in turn, is expected to drive market growth.
  • Increasing adoption of personalized medicine: The use of personalized medicine, which involves tailoring treatment plans to the specific characteristics of each patient's cancer, is increasing in Germany. This trend is expected to drive market growth as personalized medicine can improve treatment outcomes and reduce the risk of adverse effects.

Market Restraints

Some cancer therapies may not be accessible in Germany because they are either undergoing clinical trials or have not received national approval. Due to the extensive regulatory load and requirement for ethical approval, conducting clinical trials in Germany might be difficult. In 2011, the German government introduced an ‘Act on the Reform of the Market for Medicinal Products’ (AMNOG) which aimed at price regulation of cancer drugs that pushed manufacturers to opt out of the market. This created a shortage of medicines. New cancer therapies may take longer to develop as a result. Receiving payment for cancer treatments can be a difficult procedure that not always covers all of the associated costs. In Germany, there have been shortages of several cancer medications, which may have an impact on patient access to care. Branded cancer drug sales may be impacted by the introduction of generic medications to the market.

Competitive Landscape

Key Players

  • Eckert & Ziegler BEBIG,
  • Oncura Inc.
  • GE Healthcare
  • Medtronic PLC.
  • Varian Medical Systems Inc
  • Boehringer Ingelheim (GER)
  • Baxter GmbH (GER)
  • Daiichi Sankyo Europe GmbH (GER)
  • Grifols Deutschland (GER)
  • Mundipharma GmbH (GER)
  • Pfizer Pharma
  • Takeda Pharma

Notable Recent Updates

December 2022 - Pre-Clinical Oncology Program out licensed by MorphoSys - MorphoSys, a pharmaceutical company with headquarters in Germany, announced today that its fully owned subsidiary Constellation Pharmaceuticals, Inc. has signed a global licensing agreement with Novartis to conduct pre-clinical research, develop, and market its novel cancer target inhibitors. Following its purchase of Constellation Pharmaceuticals, Inc., MorphoSys expanded its portfolio of research initiatives by including this one.

August 2022 -To create novel immune-synthetic antibody-drug conjugates, Mersana Therapeutics, and Merck KGaA, Darmstadt, Germany, have announced a research collaboration and commercial license agreement. A leading science and technology company, Merck KGaA, Darmstadt, Germany, operates its biopharmaceuticals business in the United States and Canada as EMD Serono. Guardant Health, Inc. a leading precision oncology company, today announced an expanded collaboration with Merck KGaA to further leverage the GuardantInform Real-World E3vidence (RWE) platform to aid in accelerating development efforts for Merck the expanded strategic partnership will concentrate on developing therapies for key cancer indications with a high unmet need.

January 2021- BeiGene and Novartis $2,200 Mn Deal: Tislelizumab, an anti-PD1 mAb for classical Hodgkin's lymphoma and metastatic urothelial carcinoma, is licensed by Novartis from BeiGene under a contract. In addition to royalties and milestone payments, BeiGene will receive an upfront payment of $650 Mn.

Healthcare Policies and Regulatory Landscape

The Federal Joint Committee (Gemeinsamer Bundesausschuss), a public health agency authorized to establish binding regulations arising out of health reform laws voted by legislators, as well as routine decisions involving healthcare in Germany, regulates the German healthcare system. Promising new cancer research results must be implemented as soon as possible in clinical research and treatment. In order to further this objective, the German Cancer Consortium (DKTK), one of the six German Health Research Centres (DZG), was established in 2012. Germany has a medical regulating organization it is called the Federal Institute for Drugs and Medical Devices (BfArM, or Bundesinstitut für Arzneimittel und Medizinprodukte). The Federal Ministry of Health (BMG) oversees health operations.

Reimbursement Scenario

In Germany, statutory health insurance, which is required for all citizens, typically covers cancer treatment. Chemotherapy, radiation therapy, surgery, and supportive care are only a few of the cancer therapies that are covered by statutory health insurance. The particular coverage, however, may change based on the patient's insurance plan and the type of care being received. Certain therapies need the insurance provider's prior approval. In Germany, purchasing private health insurance is another alternative, which may provide additional cancer treatment coverage as well as coverage for procedures not included in the mandatory health insurance, such as some experimental therapies or complementary therapies. Private insurance plans, however, have more expensive premiums. 

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Oncology Drugs Market Segmentation

By Drug class

  • Cytotoxic drugs
    • Alkylating agents
    • Antimetabolites
    • Others
  • Targeted drugs
    • Monoclonal antibodies
    • Others
  • Hormonal drugs
  • Others

By Therapy

  • Chemotherapy
  • Targeted therapy
  • Immunotherapy

By Indication

  • Lung cancer
  • Stomach cancer
  • Colorectal cancer
  • Breast cancer
  • Prostate cancer
  • Others

By Dosage form

  • Solid
    • Tablets
    • Capsules
  • Liquid
  • Injectable
    • Prefilled syringes
    • Others

By Distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • ?Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 09 June 2023
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up